Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward
- PMID: 8587922
- DOI: 10.1016/0091-3057(95)00184-x
Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward
Abstract
Recent experiments have demonstrated that 5-HT2A antagonists can modify electrophysiological, neurochemical, and behavioral responses to psychostimulants. These findings led to an interest in using 5-HT2A antagonists to block the effects of psychostimulants on brain reward mechanisms. The present experiments assessed the ability of mixed D2/5-HT2A antagonists to reverse amphetamine-induced facilitation of self-stimulation. The D2/5-HT2A antagonists MDL 28,133A and risperidone attenuated the effects of cocaine and amphetamine, but only at antagonist doses that elevated baseline self-stimulation thresholds. A comparison of the effects of the mixed antagonists to those of haloperidol and eticlopride revealed that all four antagonists produced similar anti-stimulant effects when the influence of the drugs on baseline responding was considered. The D2 activity of the antagonists appears to account for their ability to reduce the effects of psychostimulants on self-stimulation. 5-HT2A antagonism makes a negligible contribution to the anti-amphetamine effects.
Similar articles
-
Mixed D2/5-HT2A antagonism of cocaine-induced facilitation of brain stimulation reward.Pharmacol Biochem Behav. 1998 Feb;59(2):275-80. doi: 10.1016/s0091-3057(97)00445-0. Pharmacol Biochem Behav. 1998. PMID: 9476970
-
Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.Eur J Pharmacol. 1996 Jun 13;306(1-3):23-32. doi: 10.1016/0014-2999(96)00217-8. Eur J Pharmacol. 1996. PMID: 8813611
-
Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.Schizophr Res. 2008 Oct;105(1-3):224-35. doi: 10.1016/j.schres.2008.07.005. Epub 2008 Aug 16. Schizophr Res. 2008. PMID: 18710798
-
A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine.Pharmacol Biochem Behav. 1998 May;60(1):55-60. doi: 10.1016/s0091-3057(97)00559-5. Pharmacol Biochem Behav. 1998. PMID: 9610924
-
Serotonin receptors: their key role in drugs to treat schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72. doi: 10.1016/j.pnpbp.2003.09.010. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 14642974 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources